nafamostat has been researched along with Peripheral Vascular Diseases in 2 studies
nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic
Peripheral Vascular Diseases: Pathological processes involving any one of the BLOOD VESSELS in the vasculature outside the HEART.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Urabe, Y | 1 |
| Ideishi, M | 1 |
| Sasaguri, M | 1 |
| Ikeda, M | 1 |
| Arakawa, K | 1 |
| Kizaki, Y | 1 |
| Ueki, Y | 1 |
| Yoshida, K | 1 |
| Yano, M | 1 |
| Matsumoto, K | 1 |
| Miyake, S | 1 |
| Tominaga, Y | 1 |
| Eguchi, K | 1 |
| Yano, K | 1 |
1 trial available for nafamostat and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Beneficial effects of a serine protease inhibitor in peripheral vascular disease.
Topics: Aged; Arteriosclerosis Obliterans; Benzamidines; Chronic Disease; Exercise Test; Female; Femoral Vei | 1993 |
1 other study available for nafamostat and Peripheral Vascular Diseases
| Article | Year |
|---|---|
Does the production of nitric oxide contribute to the early improvement after a single low-density lipoprotein apheresis in patients with peripheral arterial obstructive disease?
Topics: Aged; Anticoagulants; Arterial Occlusive Diseases; Benzamidines; Blood Component Removal; Bradykinin | 1999 |